Safety and efficacy of Tamsulosin as medical expulsive therapy in pregnancy
- 25 November 2019
- journal article
- research article
- Published by Springer Nature in World Journal of Urology
- Vol. 38 (9) , 2301-2306
Abstract
Use of medical expulsive therapy (MET) is common practice in urology for the treatment of symptomatic urolithiasis, despite this its efficacy is debated. Its use in pregnancy is controversial. Our objective was to evaluate the safety and efficacy of Tamsulosin as a MET in pregnant women.Keywords
This publication has 23 references indexed in Scilit:
- Contemporary best practice urolithiasis in pregnancyTherapeutic Advances in Urology, 2018
- Alpha blockers for treatment of ureteric stones: systematic review and meta-analysisBMJ, 2016
- Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART IJournal of Urology, 2016
- EAU Guidelines on Diagnosis and Conservative Management of UrolithiasisEuropean Urology, 2016
- Prevalence of Kidney Stones in the United StatesEuropean Urology, 2012
- Is There a Role for Tamsulosin in the Treatment of Distal Ureteral Stones of 7mm or Less? Results of a Randomised, Double-Blind, Placebo-Controlled TrialEuropean Urology, 2009
- Medical Therapy to Facilitate the Passage of Stones: What Is the Evidence?European Urology, 2009
- Management of Urinary Calculi in Pregnancy: A ReviewJournal of Endourology, 2008
- Medical therapy to facilitate urinary stone passage: a meta-analysisThe Lancet, 2006
- Management of urinary calculi in pregnancyUrology, 1982